Global Anti-Obesity Prescription Drugs Market to Gain Rapid Expansion During 2017-2026: Liraglutide Drug Class Anticipates to Lead
Obesity is largely considered a lifestyle disease that has become the second leading cause of preventable deaths. This disease needs proper medical attention. Prescription weight loss medication is used by doctors and physicians to cure obesity. In the present time, growing prevalence of obesity globally has led to an upsurge in demand for anti-obesity prescription drugs globally. Owing to this, the global anti-obesity prescription drugs market is expected to witness a moderate growth in the coming years, states a new...
View full press release